Through the budget rectification, CNAS has obtained a significant increase in funds for cost-volume contracts, from 6.2 billion lei to 8.5 billion lei. This amount will allow the continuation of treatments for patients benefiting from innovative therapies and will facilitate access for other patients to essential medications. The president of CNAS, Horațiu-Remus Moldovan, emphasized the importance of this decision for public health and invited pharmaceutical manufacturers to participate in negotiations for new contracts.
Sources
Cum arată rectificarea bugetară pentru Sănătate. Cât primește CNAS de la Guvern pentru medicamente și terapii inovatoare
CNAS a obţinut creşterea plafonului de negociere pentru contractele cost-volum la 8,5 miliarde lei, faţă de 6,2 miliarde lei la începutul anului / Asigură continuitatea tratamentelor pentru peste 450.000 de pacienţi care beneficiază de terapii moderne
Latest News
20:18
Poland intercepted a Russian reconnaissance aircraft over the Baltic Sea, 30 km from the coast.
19:58
Romania participated in the evacuation of five sick children from Gaza Strip, together with members of their families, as part of the 12th humanitarian operation.
19:37
Ropharma reports a net profit of 5.7 million lei, an increase of 627% compared to last year.
18:49
Shein raised 1.7 billion dollars at its listing in Hong Kong. The online retailer was valued at 26.3 billion dollars, below previous expectations.
18:35
UDMR will not leave the alliance with PNL and USR until President Nicușor Dan appoints a new prime minister. Kelemen Hunor denied the speculation regarding support for PSD.
See more news